Literature DB >> 29707675

Identification of Candida species isolated from vulvovaginitis using matrix assisted laser desorption ionization-time of flight mass spectrometry.

Majid Alizadeh1, Anna Kolecka2, Teun Boekhout2,3, Hossein Zarrinfar4, Mohamad A Ghanbari Nahzag1, Parisa Badiee5, Ali Rezaei-Matehkolaei6, Abdolmajid Fata7, Somayeh Dolatabadi8, Mohammad J Najafzadeh1,9.   

Abstract

BACKGROUND AND
PURPOSE: Vulvovaginal candidiasis (VVC) is a common problem in women. The purpose of this study was to identify Candida isolates by matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) from women with vulvovaginitis that were referred to Ghaem Hospital, Mashhad, Iran.
MATERIALS AND METHODS: This study was conducted on 65 clinical samples isolated from women that were referred to Ghaem Hospital. All specimens were identified using phenotyping techniques, such as microscopy and culture on Sabouraud dextrose agar and corn meal agar. In addition, all isolates were processed for MALDI-TOF MS identification.
RESULTS: Out of the 65 analyzed isolates, 61 (94%) samples were recognized by MALDI-TOF MS. However, the remaining four isolates (6%) had no reliable identification. According to the results, C. albicans (58.5%) was the most frequently isolated species, followed by C. tropicalis (16.9%), C. glabrata (7.7%), C. parapsilosis (7.7%), and guilliermondii (3.1%).
CONCLUSION: As the findings indicated, MALDI TOF MS was successful in the identification of clinical Candida species. C. albicans was identified as the most common Candida species isolated from the women with VVC. Moreover, C. tropicalis was the most common species among the non-albicans Candida species.

Entities:  

Keywords:  Candidiasis; Identification; MALDI-TOF MS; Vulvovaginitis

Year:  2017        PMID: 29707675      PMCID: PMC5917097          DOI: 10.29252/cmm.3.4.21

Source DB:  PubMed          Journal:  Curr Med Mycol        ISSN: 2423-3420


Introduction

Genus Candida includes more than 300 species and belongs to the kingdom fungi, Phylum Ascomycota, Subphylum Saccharomycotina, class Saccharomycetes, and order Saccharomycetales [1]. Within the last two decades, the incidence of infections due to Candida species has significantly increased [2-4]. Candida is carried by nearly half of the population as a harmless commensal [5]. In healthy individuals, the Candida colonization of body sites, including oral cavity, skin, gastrointestinal tract, and vaginal surfaces is normal [6, 7]. Vulvovaginal candidiasis (VVC) is due to the overgrowth of Candida yeast species within the vagina, which is characterized by curd-like vaginal discharge, erythema, and itching [8]. The VVC is a vaginal infection, affecting approximately 75% of the females of child-bearing age one or more times in their lifetime. This infection can occur recurrently in approximately 5% of the females [9, 10]. The VVC can not only affect the woman, but also girls. The increased susceptibility of children to VVC could be explained by several factors. These factors include anatomical features of the children (i.e., proximity to the rectum, pubic hair, small labia minora, lack of labial fat pads, thin and delicate vulvar skin, as well as thin, atrophic, and anoestrogenic vaginal mucosa), children’s tendency to explore their bodies, and poor local hygiene [11, 12]. C. albicans accounts for 80-92% of all cases of candidiasis infections worldwide, especially VVC [13-15]. However, the recurrence of non-albicans Candida species, especially C. glabrata, C. parapsilosis, and C. tropicalis has increased in the healthy females [16]. Most of the commonly isolated yeast species can be identified by the commercially available biochemical test systems. However, the rarely occurring species often remains unidentified or misidentified [17-19]. Additionally, phenotypic tests require 1-3 days of incubation to obtain results. To overcome the inaccuracies of biochemical identification methods, molecular methods have been developed. The molecular identification tests for yeasts are based on a polymerase chain reaction amplification, followed by the sequencing of the internal transcribed spacer region and the D1/D2 domains of the large subunit of the ribosomal DNA [20-23]. While these assays are highly accurate, they require considerable processing time and expensive reagents. As an alternative to biochemical and molecular identification schemes, matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) can be used for the reliable identification of Candida species. Moreover, this method has been recently used for the routine identification of microorganisms, especially bacteria and yeasts, in clinical centers in several parts of the world [24-26]. The MALDI-TOF MS facilitates the identification of a large spectrum of proteins directly from intact microorganisms [27]. This method has been shown to precisely detect bacteria and yeast at the species level [28]. Within this technique, spectra are compared to a reference database, and recognition is acquired by matching the unknown spectrum to the most similar spectrum in the database to identify the unknown microorganism [29]. With this background in mind, the present study was performed to identify Candida species from women suffering from vulvovaginitis that were referred to Ghaem Hospital, Mashhad, Iran, by means of MALDI-TOF MS.

Materials and Methods

This study was conducted on 65 samples obtained from the women with VVC through routine measures at Ghaem Hospital Mashhad, Iran. The exclusion criteria were negative culture result and contamination by saprobic fungi. This study was approved by the Ethics Committee of Mashhad University of Medical Sciences, Mashhad, Iran (ethical code: IR.MUMS.REC.1393.762). All isolates were cultured onto Sabouraud dextrose agar and incubated for 2-3 days at 30°C. The isolates were stained by Giemsa staining. A germ tube test and the formation of chlamydospores were assessed for the confirmation of the genus Candida [30]. All yeast isolates were subcultured on Sabouraud dextrose agar plates and incubated at 30°C for 24 h. Yeast proteins were extracted according to the Bruker Daltonics GmbH protocol using the formic acid/ethanol extraction protocol [31, 32]. Briefly, a single colony of the sample isolates were suspended in 300 µL of Milli-Q water. A formic acid volume of 30-50 µL was found to be optimal, and an equal volume of acetonitrile was added later on. From the crude protein extracted from each tested strain, 1 µL was spotted in duplicate on a 96-spot polished steel target plate (Bruker Daltonics, Bremen, Germany) and allowed to air drying. The bacterial test standard was utilized as a positive control (Bruker Daltonics). Prior to analysis, all tested spots were overlaid with 1 μL of alpha-cyano-4-hydroxycinnamic acid (Bruker Daltonics). After drying at room temperature they were analyzed in automatic runs operated by flexControl, version 3.3.108.0 (Bruker Daltonics). The yeast identification was accomplished by means of MALDI-TOF MS Biotyper RTC software, version 3.0 (Bruker Daltonics), based on the comparison of mass spectra generated by the Microflex LT software with databases. The recognition results were scored according to the manufacturer’s criteria. In this regard, the log score values of > 2.0, 1.7-2, and < 1.7 indicated correct species identification, correct genus identification, and no reliable identification, respectively. The obtained mass spectra were visualized as described by Cendejas-Bueno et al. [33]. The identification was considered precise if at least one spot from the duplicates had a score of > 1.7 and gave reliable identification.

Results

Candida isolates obtained from VVC could not be entirely recognized at the species level by biochemical methods. Out of the 65 analyzed isolates, 93.8% of the samples were identified by MALDI-TOF MS (Table 1). According to the results, C. albicans was the most frequently isolated species (58.5 %, n=38), while other Candida species comprised 41.5% (n=27) of the samples. These species included C. glabrata (7.7 %, n=5), C. tropicalis (16.9%, n=11), C. parapsilosis (7.7%, n=5), and Meyerozyma guilliermondii (3.1%, n=2). The MALDI-TOF MS failed to correctly identify four species (6.1 %, n=4).
Table 1

Results of matrix assisted laser desorption ionization-time of flight mass spectrometry identification of 65 isolates analyzed with Bruker Daltonics

Candida spp. No. of analyzed isolates (%) No. with MALDI-TOF score
>2.0 1.7-2.0 <1.7
Candida albicans 38 (58.5)371
Candida tropicalis 11 (16.9)92
Candida glabrata 5 (7.7)5
Candida parapsilosis 5 (7.7)5
Meyerozyma guillermondii 2 (3.1)2
Species not included in database4 (6.1)4
Total655834

MALDI-TOF: matrix assisted laser desorption ionization-time of flight mass spectrometry

Overall, 58 (89.2%), 3 (4.6%), and 4 (6.2%) isolates had correct species identification level (i.e., log score value of >2.0), genus level (log score value of 1.7-2.0), and no reliable identification (log score value of <1.7) respectively. The performance of MALDI -TOF MS for the routine identification of the clinical isolates is tabulated in Table 1. Results of matrix assisted laser desorption ionization-time of flight mass spectrometry identification of 65 isolates analyzed with Bruker Daltonics MALDI-TOF: matrix assisted laser desorption ionization-time of flight mass spectrometry

Discussion

In the present study, we used MALDI-TOF MS for the identification of Candida species isolated from VVC and evaluated the prevalence of each species. Although the conventional biochemical screening for yeast recognition is cheap, it is time-consuming and occasionally incorrect [17-19]. On the other hand, gene sequencing is precise, but high-priced, time-consuming, technically demanding, and not always available for routine identification [23]. Bacteria cause 40-50% of cases of vaginal infections, and Candida species accounts for 20-25% of the cases [14]. The pathogenesis of VVC due to Candida species is complex and depends on host factors and fungal species involved. These factors may increase the recurrent experience of candidiasis and make the treatment process more complicated [34, 35]. However, the correct identification of Candida species and targeted antifungal therapy can reduce antifungal drug resistance in these species. Among the clinically relevant Candida species, C. albicans has a low azole resistance rate. Nonetheless, the prevalence of other species, such as C. krusei and C. glabrata, which are resistant to triazole and especially fluconazole is on a rising trend [36]. The MALDI-TOF MS as a new technique has emerged for the identification of clinical yeast and yeast-like isolates. The utilization of either on-plate extraction or standard tube-based methods provides a precise identification for most of the yeast isolates within 10-40 min with only 5 min of hands-on time [32, 37]. Preparation for MALDI-TOF MS analysis, including protein extraction, requires almost cheap reagents [37]. While the MALDI-TOF MS instrument is expensive, the use of cheap reagents and high recognition rates significantly decrease the cost for the identification of organisms in comparison to the current techniques [37]. In addition to the detection of Candida species, this technique has also been used for the identification of other fungal species, such as other yeasts [26, 27, 38-41], dermatophyte species [42-44], and filamentous fungi, like Aspergillus species [27, 45-47]. In line with the literature, in this study C. albicans (58.5%) was the most prevalent species associated with VVC [15]. Likewise, in an epidemiologic study of VVC cases, C. albicans was the most prevalent cause as well [48]. The incidence of C. albicans in pregnant woman is higher than in non-pregnant ones. This is due to the fact that C. albicans is able to adhere to vaginal epithelium more readily than other Candida species [49]. In our study, 94% of the isolates were recognized by MALDI-TOF MS. Similarly, in another study on clinical yeast isolates, MALDI-TOF MS facilitated the identification of 92.5% of samples [32]. Pulcrano et al. [50] and Yaman et al. [51] could identify 100% of Candida isolates through this method. Based on the findings, it can be concluded that MALDI-TOF MS is a rapid and accurate technique for the identification of Candida species isolated from VVC.

Conclusion

As the findings of the present study indicated, MALDI TOF MS method was successfully used for the identification of clinical Candida species. In the current study, C. albicans and C. tropicalis were identified as the dominant yeast Candida species isolated from women with VVC, respectively.
  48 in total

Review 1.  Yeast identification in the clinical microbiology laboratory: phenotypical methods.

Authors:  A M Freydiere; R Guinet; P Boiron
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

2.  Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species.

Authors:  Lindsay G Stevenson; Steven K Drake; Yvonne R Shea; Adrian M Zelazny; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

3.  Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and a commercial extraction system: analysis of performance, cost, and turnaround time.

Authors:  Philippe R S Lagacé-Wiens; Heather J Adam; James A Karlowsky; Kimberly A Nichol; Paulette F Pang; Jodi Guenther; Amanda A Webb; Crystal Miller; Michelle J Alfa
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

4.  Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals.

Authors:  Boualem Sendid; Patrick Ducoroy; Nadine François; Geraldine Lucchi; Sebastien Spinali; Odile Vagner; Sebastien Damiens; Alain Bonnin; Daniel Poulain; Frederic Dalle
Journal:  Med Mycol       Date:  2012-06-18       Impact factor: 4.076

5.  Comparative study of seven commercial yeast identification systems.

Authors:  P E Verweij; I M Breuker; A J Rijs; J F Meis
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

6.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

7.  High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories.

Authors:  S Q van Veen; E C J Claas; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

8.  Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting.

Authors:  Justin M Hettick; Brett J Green; Amanda D Buskirk; Michael L Kashon; James E Slaven; Erika Janotka; Francoise M Blachere; Detlef Schmechel; Donald H Beezhold
Journal:  Anal Biochem       Date:  2008-06-05       Impact factor: 3.365

9.  High prevalence of candiduria due to non-albicans Candida species among diabetic patients: A matter of concern?

Authors:  Alireza Esmailzadeh; Hossein Zarrinfar; AbdolMajid Fata; Tanuka Sen
Journal:  J Clin Lab Anal       Date:  2017-10-27       Impact factor: 2.352

10.  Vulvovaginal candidiasis in Mato Grosso, Brazil: pregnancy status, causative species and drugs tests.

Authors:  Luciana Basili Dias; Márcia de Souza Carvalho Melhem; Maria Walderez Szeszs; José Meirelles Filho; Rosane Christine Hahn
Journal:  Braz J Microbiol       Date:  2011-12-01       Impact factor: 2.476

View more
  8 in total

1.  Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles.

Authors:  Narges Aslani; Roya Kokabi; Fatemeh Moradi; Kiana Abbasi; Narges Vaseghi; Mohammad Hosein Afsarian
Journal:  Curr Med Mycol       Date:  2021-12

2.  Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence.

Authors:  Lívia Custódio Pereira; Amabel Fernandes Correia; Zita Dinis Lopes da Silva; Ceres Nunes de Resende; Fabiana Brandão; Rosane Mansan Almeida; Yanna Karla de Medeiros Nóbrega
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-13       Impact factor: 3.267

3.  Kinetics of antifungal activity of home-generated ozonated water on Candida albicans.

Authors:  Amirtaher Mirmortazavi; Hamidreza Rajati Haghi; Abdolmajid Fata; Hossein Zarrinfar; Hossein Bagheri; Amirhossein Mehranfard
Journal:  Curr Med Mycol       Date:  2018-06

4.  Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae.

Authors:  Seyed Ebrahim Hashemi; Tahereh Shokohi; Mahdi Abastabar; Narges Aslani; Mahbobeh Ghadamzadeh; Iman Haghani
Journal:  Curr Med Mycol       Date:  2019

5.  Development a hydrolysis probe-based quantitative PCR assay for the specific detection and quantification of Candida auris.

Authors:  Hadis Jafarian; Hossein Khodadadi; Parisa Badiee
Journal:  Curr Med Mycol       Date:  2020-09

6.  High incidence of azole resistance among Candida albicans and C. glabrata isolates in Northeastern Iran.

Authors:  Hossein Zarrinfar; Zahra Kord; Abdolmajid Fata
Journal:  Curr Med Mycol       Date:  2021-09

7.  In vitro and in vivo antifungal activity of Allium hirtifolium and Allium sativum.

Authors:  Alireza Diba; Fahimeh Alizadeh
Journal:  Avicenna J Phytomed       Date:  2018 Sep-Oct

8.  Antifungal and Antivirulence Activity of Vaginal Lactobacillus Spp. Products against Candida Vaginal Isolates.

Authors:  Camilla Itapary Dos Santos; Yasmine Ramos França; Carmem Duarte Lima Campos; Maria Rosa Quaresma Bomfim; Bruna Oliveira Melo; Rodrigo Assunção Holanda; Vera Lucia Santos; Sílvio Gomes Monteiro; Eduardo Buozzi Moffa; Andrea Souza Monteiro; Cristina Andrade Monteiro; Valério Monteiro-Neto
Journal:  Pathogens       Date:  2019-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.